149 related articles for article (PubMed ID: 24066798)
1. Modeling study of phenylsulfonylfuroxan derivatives as P-gp inhibitors: a combined approach of CoMFA, CoMSIA and HQSAR.
Gadhe CG; Balupuri A; Balasubramanian PK; Cho SJ
Anticancer Agents Med Chem; 2014; 14(7):1019-30. PubMed ID: 24066798
[TBL] [Abstract][Full Text] [Related]
2. In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series.
Gadhe CG; Madhavan T; Kothandan G; Cho SJ
BMC Struct Biol; 2011 Jan; 11():5. PubMed ID: 21269449
[TBL] [Abstract][Full Text] [Related]
3. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
Jiang YR; Yang YY; Chen YL; Liang ZJ
Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
[TBL] [Abstract][Full Text] [Related]
4. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
5. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
6. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
7. Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance.
Kaiser D; Smiesko M; Kopp S; Chiba P; Ecker GF
Med Chem; 2005 Sep; 1(5):431-44. PubMed ID: 16787327
[TBL] [Abstract][Full Text] [Related]
8. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
9. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
[TBL] [Abstract][Full Text] [Related]
10. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
11. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
12. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
[TBL] [Abstract][Full Text] [Related]
13. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
[TBL] [Abstract][Full Text] [Related]
14. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
Teixeira C; Gomes JR; Couesnon T; Gomes P
J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
Kaur K; Talele TT
J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
[TBL] [Abstract][Full Text] [Related]
17. Computational studies of TGF-βRI (ALK-5) inhibitors: analysis of the binding interactions between ligand-receptor using 2D and 3D techniques.
Araujo SC; Maltarollo VG; Honorio KM
Eur J Pharm Sci; 2013 Jul; 49(4):542-9. PubMed ID: 23727056
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
19. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
20. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]